Hear from the CEO of a startup that is looking to synthesize CBD for a fraction of the cost of hemp-derived CBD...

You must subscribe to Cannabis IPO Insider to view this content.

To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.